Public Notice of the Draft Environmental Impact Report for the Nucleic Acid Vaccine R&D and Pilot-Scale Production Project

Release date:

2024-09-13

Author:

Source:


Abstract

I. Methods for Obtaining the Draft for Public Comment 1. Paper Version: The public may review the document at Beijing Minhai Biotechnology Co., Ltd. 2. Electronic Version: Please refer to the attached file. II. Scope of the Public Subject to Comment The scope of this public consultation is limited to citizens, legal entities, and other organizations that are affected by or have a vested interest in the nucleic acid vaccine research and development and pilot‑scale production project. III. Online Link to the Public Comment Form During the period of public notice, if the public has any comments or views regarding the project’s construction or the environmental impact assessment, please complete the Public Comment Form and submit it to the project proponent. Link to download the Public Comment Form: http://www.mee.gov.cn/x

I. Method for Obtaining the Draft for Public Comment

1 , Obtaining the Paper Version

The public may inspect the documents at Beijing Minhai Biotechnology Co., Ltd.

2 , Electronic Version Available

Link: https://pan.baidu.com/s/1dT1iSCN6bnA_MgRWd945GA Extraction code: qyqx. The public can download it directly from this link.

II. Scope of the Public Involved in Soliciting Opinions

The scope of the public consultation for this project is limited to citizens, legal persons, and other organizations that are affected by or have a vested interest in the nucleic acid vaccine research and development and pilot‑scale production project.

III. Online Link to the Public Comment Form

During the public notice period, if the public has any comments or views regarding the project’s construction and the environmental impact assessment, please complete the Public Comments Form and submit it to the project proponent. Link to download the Public Comments Form: http://www.mee.gov.cn/xxgk2018/xxgk/xxgk01/201810/t20181024_665329.html Attachment 1

IV. Methods and Channels for Public Comment

The public may download the public comment form, complete it in full, and submit it to the project proponent by mail, in person, or via email.

V. Period for Public Submission of Comments

Effective from the date of promulgation 10 Within one business day.

VI. Contact Information

Construction Entity: Beijing Minhai Biotechnology Co., Ltd.

Contact: Zhang Yidi

Email: zhangyidi@biominhai.com

Contact number: 15501168808

Contact Address: No. 25, Tianfu Street, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing

Construction Entity: Beijing Minhai Biotechnology Co., Ltd.

2024 year 9 month 13 day

 

 

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09